TATAA Biocenter goes live with a modern, fully-automated LIMS –
a big day for their state-of-the-art laboratory in Gothenburg.

View Preview

It’s been over 12 months in the making and TATAA Biocenter has now gone live with its Laboratory Information Management System (LIMS) from Benchling. Integrating processes, samples, instruments, and informatics into one automated and unified platform.

Effectively managing sequencing and PCR data can be challenging, with issues in data security and sample management and potential mistakes caused by human error.

A modern LIMS solution allows you to connect everything in the laboratory so you can record and trace all that you do to an individual sample. Every process, every measurement.

“LIMS is a way to bulletproof your processes. A customer will be able to follow the whole process of a sample, every concentration, how many PCR cycles. It makes it easy to trouble-shoot issues or biases with a specific sample, since you have all the data collected and stored, and traceable. That can’t be deleted.” says Sofia Adolfsson, Head of Bioinformatics, TATAA Biocenter.

The LIMS has been set up specifically for the needs of TATAA Biocenter and will stand out to customers as a critical competitive differentiator.

This LIMS solution seamlessly integrates TATAA’s key laboratory instruments, including the NGS star Library Prep and Illumina sequencers, improving quality control while increasing throughput and productivity, for NGS and dPCR analysis.

TATAA Biocenter selected Benchling as its LIMS platform for its end-to-end solution and robust compliance capabilities. The R&D Cloud provides a centralised source of truth, so users don’t need to capture and manage data in multiple places and systems. This will also help with future compliance requirements, such as 21 CFR Part 11 compliance/GLP.

TATAA Biocenter and Benchling collaborated closely throughout the entire project, working side-by side, going through each process, in a detailed way, to make sure everything in the laboratory was documented.

“During this integration, we considered ourselves as an integral and embedded part of the team at TATAA Biocenter, finding the right approach to serve them at every step of their journey,” said Abdel Batel, Head of Professional Services EMEA, Benchling. “We know that with Benchling, TATAA Biocenter laboratory is equipped with the most trusted, high-quality tools that empower their customers to increase productivity and shorten delivery times with R&D.”

With Benchling’s LIMS solution, TATAA ensures the capture of high-quality, structured and unstructured data for customers, which is critical to scientists’ ability to ask and answer new questions. It is purpose built for science — capturing DNA, RNA, proteins, and more — and structures the data in a way that is accessible, interoperable, and reusable.

This focus on data quality and structure helps TATAA and its customers manage their intellectual property more effectively, making it easier for R&D teams to maintain IP security and streamline the process of IP transfer that occurs when organisations combine or partner.

The LIMS has been set up specifically for the needs of TATAA Biocenter and will stand out to customers as a critical competitive differentiator. A tailored and unique system that brings many benefits to TATAA’s scientists and customers.


If you would like more information about TATAA Biocenter please contact us

About TATAA Biocenter
TATAA Biocenter is a leading provider of molecular services to the Advanced Therapies and Medical products (ATMP) industry in Europe and to the Cell and Gene Therapy industry in the United States. With ISO 17025 accreditation and Good Laboratory and Clinical Practices (GLP/GCP) eady facility TATAA is perfectly positioned to support the pharmaceutical industry with biomarker profiling including genomics, transcriptomics, and proteomics with traditional qPCR, dPCR and NGS methods as well as proprietary methods.

About Benchling
Benchling is the pioneer of the R&D Cloud, software that unlocks the power of biotechnology. More than 200,000 scientists at over 1,000 companies and 7,500 academic and research institutions globally have adopted the Benchling R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster. The Benchling R&D Cloud helps these organizations modernize their scientific processes and accelerate collaboration so they can convert the complexity of biology into world-changing results. For more, please visit Benchling.com or follow us on Twitter at @Benchling.